The obesity paradox in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

The obesity paradox in metastatic castration-resistant prostate cancer

Published:2021-07-05 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Martini Alberto^ORCID,Shah Qainat N.,Waingankar Nikhil,Sfakianos John P.,Tsao Che-Kai,Necchi Andrea,Montorsi Francesco,Gallagher Emily J.^ORCID,Galsky Matthew D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-021-00418-0.pdf

Reference27 articles.

1. Organization WH. Obesity https://www.who.int/topics/obesity/en/.

2. Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, et al. Vital Signs: trends in Incidence of Cancers Associated with Overweight and Obesity - United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2017;66:1052–8.

3. Armstrong AJ, Halabi S, de Wit R, Tannock IF, Eisenberger M. The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2009;12:88–93.

4. Cushen SJ, Power DG, Murphy KP, McDermott R, Griffin BT, Lim M, et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clin Nutr ESPEN. 2016;13:e39–e45.

5. Halabi S, Small EJ, Vogelzang NJ. Elevated Body Mass Index Predicts for Longer Overall Survival Duration in Men With Metastatic Hormone-Refractory Prostate Cancer. J Clin Oncol. 2005;23:2434–5.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An analysis of the relationship of triglyceride glucose index with gastric cancer prognosis: A retrospective study;Cancer Medicine;2024-01-11

2. The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real‐world multicenter analysis;Cancer Medicine;2024-01

3. Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration‐resistant prostate cancer treated with abiraterone or enzalutamide;The Prostate;2023-11

4. Association between adiposity after diagnosis of prostate cancer and mortality: systematic review and meta-analysis;BMJ Medicine;2023-06

5. The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review;BJUI Compass;2023-04-06